MISSION
Discover and develop innovative 2D and 3D screening and testing platforms using primary cells and proteomic and transcriptomic approaches.
VISION
Transform our scientific results into cost-effective and pionering services to help our clients to develop novel and disruptive actives.
VALUE DRIVERS
Quick ingredient functionality overview.- Accelerated time to market.
- Competitive price.
- Reliability and scientific support.
- Confidentiality.
Our Platforms
Platform
Cellular Assays
- Testing in proprietary and validated human primary immortalized skin cells.
- Flexible platform which customer can choose up to 25 targets and 31 end-points.
- You can design your primary screening
and confirmatory assays. - Novel targets are always in development.
Open and Flexible Platform
BBIOMIC®is an unique PEA-based multiplexed platform to investigate and validate cosmetic ingredients for specific claims.
PEA is a novel multiplex technology developed to measure secreted proteins in serum, plasma and culture supernatants. The technology has been proven to possess exceptional readout specificity and sensitivity, enabling high multiplex assays with coverage across a broad dynamic range. BBIOMIC® explores the levels of 20 validated proteins of cosmetic interest secreted by dermal primary cells in a single well.
- BBIOMIC platform validated in human primary cells.
- Unique PEA-platform designed for cosmetic research.
- Superior sensitivity to other immuno-based assays.
- Flexible platform, customer can choose specific treatment and cell type.
- 20 selected proteins for a wide number of specific claims.
Cell Types
